Abstract:Objectives: Hypoxia is associated with human non-small cell lung cancers (NSCLC), which are highly resistant to chemotherapy. The hypoxia inducible factor (HIF) as a transcription factor in response to hypoxia indicates that it could be a novel, tumor-specific target for anticancer therapy. We hypothesized that disruption of HIF pathway through lentiviral vector-mediated HIF-1 alpha RNA interference (RNAi) could reverse the hypoxia-induced resistance to chemotherapy. Methods: We transfected Human NSCLC cell lines, SPCA1 and A549 with HIF-1 alpha specific RNAi lentiviral vectors as well as controls. HIF-1 alpha silenced cells [SPCA1/HIF-1 alpha(-) and A549/HIF-1 alpha(-)] were screened by blasticidin. They were incubated in 19 or 0.5% O-2 for 16 h followed by the assessment of chemosensitivity to cisplatin and doxorubicin with MTT and clonogenic assays. Quantitative RT-PCR and Western blot analysis were used to detect the expressions of HIF-1 alpha mRNA and protein, respectively. Moreover, flow cytometry was used to monitor the expression of P-glycoprotein. Results: Exposure of SPCA1 and A549 cells to 0.5% O-2 significantly increased resistance to cisplatin and doxorubicin, in contrast to cells incubated in normoxia. Transduction of SPCA1 with HIF-1 alpha RNAi vector resulted in sequence specific silencing with 87.2 and 84.6% decreases of HIF-1 alpha mRNA transcription and 97.3 and 94.8% of protein expressions in normoxia and hypoxia, respectively. Correspondingly, they are 89.2, 89.9% and 97.2, 88.4% decreases in A549 cells. Hypoxia-induced resistance to cisplatin and doxorubicin were reversed in SPCA1/HIF-1 alpha(-) and A549/HIF-1 alpha(-) cells. There was no significant P-glycoprotein increase induced by hypoxia in NSCLC cells. Conclusions: Our studies demonstrated that hypoxia-induced chemoresistance to cisplatin and doxorubicin in NSCLC cells is through the HIF pathway. MDR1 regulation may not be involved in hypoxia-induced chemoresistance. Combining delivery of HIF-1 alpha RNAi lentiviral vector with cisplatin-related chemotherapy regimens may enable us to develop more effective strategy for NSCLC therapy.

HIF1 regulates WSB-1 expression to promote hypoxia-induced chemoresistance in hepatocellular carcinoma cells.

Transcriptional Upregulation of Hsp70-2 by Hif-1 in Cancer Cells in Response to Hypoxia

Identification of Cathepsin B As a Novel Target of Hypoxia-Inducible Factor-1-alpha in HepG2 Cells.

The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma.

Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma

Egr-1 Promotes Hypoxia-Induced Autophagy to Enhance Chemo-Resistance of Hepatocellular Carcinoma Cells.

Hypoxia-Induced Wsb1 Promotes the Metastatic Potential of Osteosarcoma Cells

Transcriptional activation of S100A2 expression by HIF-1α via binding to the hypomethylated hypoxia response elements in HCC cells

Aberrantly Expressed HIF-1α Enhances HCC Stem Cell-Like Traits Via Wnt/β-catenin Signaling Activation after Insufficient Radiofrequency Ablation.

Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma

Regulation of hypoxia inducible factor-1α expression by the alteration of redox status in HepG2 cells

Upregulation of Heat Shock Factor 1 Transcription Activity is Associated with Hepatocellular Carcinoma Progression.

Effects of lentivirus-mediated HIF-1α knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells

Hypoxia-Induced Resistance To Cisplatin And Doxorubicin In Non-Small Cell Lung Cancer Is Inhibited By Silencing Of Hif-1 Alpha Gene

The role of hepatitis B virus X protein in regulation of hypoxia inducible factor-1αand the underlying mechanisms in hepatocellular carcinoma

Activation Of Pi3 Kinase/Akt/Hif-1 Alpha Pathway Contributes To Hypoxia-Induced Epithelial-Mesenchymal Transition And Chemoresistance In Hepatocellular Carcinoma

HIF-1α plays a role in the chemotactic migration of hepatocarcinoma cells through the modulation of CXCL6 expression.

Regulation Of Hypoxia Inducible Factor-1 Alpha Expression By The Alteration Of Redox Status In Hepg2 Cells

The hypoxia-inducible factor 1 inhibitor LW6 mediates the HIF-1α/PD-L1 axis and suppresses tumor growth of hepatocellular carcinoma in vitro and in vivo

Identification of Genes Involved in Adaptive Response to Hypoxia and Their Expression Attenuations by Gene Silencing of HIF-1α in A549 Lung Cancer Cells

WSB1 Promotes Tumor Metastasis by Inducing Pvhl Degradation